Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1989 Oct 1;109(4):1385–1387. doi: 10.1083/jcb.109.4.1385

ADP-ribosylation of actin by clostridial toxins

PMCID: PMC2115792  PMID: 2677017

Full Text

The Full Text of this article is available as a PDF (443.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aktories K., Ankenbauer T., Schering B., Jakobs K. H. ADP-ribosylation of platelet actin by botulinum C2 toxin. Eur J Biochem. 1986 Nov 17;161(1):155–162. doi: 10.1111/j.1432-1033.1986.tb10136.x. [DOI] [PubMed] [Google Scholar]
  2. Aktories K., Bärmann M., Ohishi I., Tsuyama S., Jakobs K. H., Habermann E. Botulinum C2 toxin ADP-ribosylates actin. Nature. 1986 Jul 24;322(6077):390–392. doi: 10.1038/322390a0. [DOI] [PubMed] [Google Scholar]
  3. Al-Mohanna F. A., Ohishi I., Hallett M. B. Botulinum C2 toxin potentiates activation of the neutrophil oxidase. Further evidence of a role for actin polymerization. FEBS Lett. 1987 Jul 13;219(1):40–44. doi: 10.1016/0014-5793(87)81187-0. [DOI] [PubMed] [Google Scholar]
  4. Böttinger H., Reuner K. H., Aktories K. Inhibition of histamine release from rat mast cells by botulinum C2 toxin. Int Arch Allergy Appl Immunol. 1987;84(4):380–384. doi: 10.1159/000234453. [DOI] [PubMed] [Google Scholar]
  5. Geipel U., Just I., Schering B., Haas D., Aktories K. ADP-ribosylation of actin causes increase in the rate of ATP exchange and inhibition of ATP hydrolysis. Eur J Biochem. 1989 Jan 15;179(1):229–232. doi: 10.1111/j.1432-1033.1989.tb14545.x. [DOI] [PubMed] [Google Scholar]
  6. Korn E. D. Actin polymerization and its regulation by proteins from nonmuscle cells. Physiol Rev. 1982 Apr;62(2):672–737. doi: 10.1152/physrev.1982.62.2.672. [DOI] [PubMed] [Google Scholar]
  7. Matter K., Dreyer F., Aktories K. Actin involvement in exocytosis from PC12 cells: studies on the influence of botulinum C2 toxin on stimulated noradrenaline release. J Neurochem. 1989 Feb;52(2):370–376. doi: 10.1111/j.1471-4159.1989.tb09131.x. [DOI] [PubMed] [Google Scholar]
  8. Mauss S., Koch G., Kreye V. A., Aktories K. Inhibition of the contraction of the isolated longitudinal muscle of the guinea-pig ileum by botulinum C2 toxin: evidence for a role of G/F-actin transition in smooth muscle contraction. Naunyn Schmiedebergs Arch Pharmacol. 1989 Sep;340(3):345–351. doi: 10.1007/BF00168521. [DOI] [PubMed] [Google Scholar]
  9. Norgauer J., Kownatzki E., Seifert R., Aktories K. Botulinum C2 toxin ADP-ribosylates actin and enhances O2- production and secretion but inhibits migration of activated human neutrophils. J Clin Invest. 1988 Oct;82(4):1376–1382. doi: 10.1172/JCI113741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ohishi I. Activation of botulinum C2 toxin by trypsin. Infect Immun. 1987 Jun;55(6):1461–1465. doi: 10.1128/iai.55.6.1461-1465.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ohishi I., Iwasaki M., Sakaguchi G. Purification and characterization of two components of botulinum C2 toxin. Infect Immun. 1980 Dec;30(3):668–673. doi: 10.1128/iai.30.3.668-673.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ohishi I. Lethal and vascular permeability activities of botulinum C2 toxin induced by separate injections of the two toxin components. Infect Immun. 1983 Apr;40(1):336–339. doi: 10.1128/iai.40.1.336-339.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ohishi I., Miyake M. Binding of the two components of C2 toxin to epithelial cells and brush borders of mouse intestine. Infect Immun. 1985 Jun;48(3):769–775. doi: 10.1128/iai.48.3.769-775.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ohishi I., Odagiri Y. Histopathological effect of botulinum C2 toxin on mouse intestines. Infect Immun. 1984 Jan;43(1):54–58. doi: 10.1128/iai.43.1.54-58.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ohishi I. Response of mouse intestinal loop to botulinum C2 toxin: enterotoxic activity induced by cooperation of nonlinked protein components. Infect Immun. 1983 May;40(2):691–695. doi: 10.1128/iai.40.2.691-695.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pollard T. D., Cooper J. A. Actin and actin-binding proteins. A critical evaluation of mechanisms and functions. Annu Rev Biochem. 1986;55:987–1035. doi: 10.1146/annurev.bi.55.070186.005011. [DOI] [PubMed] [Google Scholar]
  17. Pollard T. D. Rate constants for the reactions of ATP- and ADP-actin with the ends of actin filaments. J Cell Biol. 1986 Dec;103(6 Pt 2):2747–2754. doi: 10.1083/jcb.103.6.2747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Popoff M. R., Boquet P. Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin. Biochem Biophys Res Commun. 1988 May 16;152(3):1361–1368. doi: 10.1016/s0006-291x(88)80435-2. [DOI] [PubMed] [Google Scholar]
  19. Popoff M. R., Rubin E. J., Gill D. M., Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun. 1988 Sep;56(9):2299–2306. doi: 10.1128/iai.56.9.2299-2306.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Reuner K. H., Presek P., Boschek C. B., Aktories K. Botulinum C2 toxin ADP-ribosylates actin and disorganizes the microfilament network in intact cells. Eur J Cell Biol. 1987 Feb;43(1):134–140. [PubMed] [Google Scholar]
  21. Schering B., Bärmann M., Chhatwal G. S., Geipel U., Aktories K. ADP-ribosylation of skeletal muscle and non-muscle actin by Clostridium perfringens iota toxin. Eur J Biochem. 1988 Jan 15;171(1-2):225–229. doi: 10.1111/j.1432-1033.1988.tb13780.x. [DOI] [PubMed] [Google Scholar]
  22. Simpson L. L. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins. J Pharmacol Exp Ther. 1982 Dec;223(3):695–701. [PubMed] [Google Scholar]
  23. Simpson L. L. Molecular basis for the pharmacological actions of Clostridium botulinum type C2 toxin. J Pharmacol Exp Ther. 1984 Sep;230(3):665–669. [PubMed] [Google Scholar]
  24. Simpson L. L., Stiles B. G., Zepeda H. H., Wilkins T. D. Molecular basis for the pathological actions of Clostridium perfringens iota toxin. Infect Immun. 1987 Jan;55(1):118–122. doi: 10.1128/iai.55.1.118-122.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Simpson L. L., Stiles B. G., Zepeda H., Wilkins T. D. Production by Clostridium spiroforme of an iotalike toxin that possesses mono(ADP-ribosyl)transferase activity: identification of a novel class of ADP-ribosyltransferases. Infect Immun. 1989 Jan;57(1):255–261. doi: 10.1128/iai.57.1.255-261.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Simpson L. L., Zepeda H., Ohishi I. Partial characterization of the enzymatic activity associated with the binary toxin (type C2) produced by Clostridium botulinum. Infect Immun. 1988 Jan;56(1):24–27. doi: 10.1128/iai.56.1.24-27.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Singer S. J., Kupfer A. The directed migration of eukaryotic cells. Annu Rev Cell Biol. 1986;2:337–365. doi: 10.1146/annurev.cb.02.110186.002005. [DOI] [PubMed] [Google Scholar]
  28. Stiles B. G., Wilkins T. D. Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity. Infect Immun. 1986 Dec;54(3):683–688. doi: 10.1128/iai.54.3.683-688.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Vandekerckhove J., Schering B., Bärmann M., Aktories K. Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. J Biol Chem. 1988 Jan 15;263(2):696–700. [PubMed] [Google Scholar]
  30. Vandekerckhove J., Schering B., Bärmann M., Aktories K. Clostridium perfringens iota toxin ADP-ribosylates skeletal muscle actin in Arg-177. FEBS Lett. 1987 Dec 10;225(1-2):48–52. doi: 10.1016/0014-5793(87)81129-8. [DOI] [PubMed] [Google Scholar]
  31. Vandekerckhove J., Weber K. The complete amino acid sequence of actins from bovine aorta, bovine heart, bovine fast skeletal muscle, and rabbit slow skeletal muscle. A protein-chemical analysis of muscle actin differentiation. Differentiation. 1979;14(3):123–133. doi: 10.1111/j.1432-0436.1979.tb01021.x. [DOI] [PubMed] [Google Scholar]
  32. Wegner A., Aktories K. ADP-ribosylated actin caps the barbed ends of actin filaments. J Biol Chem. 1988 Sep 25;263(27):13739–13742. [PubMed] [Google Scholar]
  33. Wegner A., Isenberg G. 12-fold difference between the critical monomer concentrations of the two ends of actin filaments in physiological salt conditions. Proc Natl Acad Sci U S A. 1983 Aug;80(16):4922–4925. doi: 10.1073/pnas.80.16.4922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weigt C., Just I., Wegner A., Aktories K. Nonmuscle actin ADP-ribosylated by botulinum C2 toxin caps actin filaments. FEBS Lett. 1989 Mar 27;246(1-2):181–184. doi: 10.1016/0014-5793(89)80279-0. [DOI] [PubMed] [Google Scholar]
  35. Zepeda H., Considine R. V., Smith H. L., Sherwin J. R., Ohishi I., Simpson L. L. Actions of the Clostridium botulinum binary toxin on the structure and function of Y-1 adrenal cells. J Pharmacol Exp Ther. 1988 Sep;246(3):1183–1189. [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES